Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers-Reference-Cited by-同舟云学术

Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers

Published:2020-12 Issue: Volume:6 Page:100075
ISSN:2590-1362
Container-title:Vaccine: X
language:en
Short-container-title:Vaccine: X

Author:

Dellepiane Nora,Pagliusi Sonia,Akut Prashant,Comellas Sebastian,De Clercq Norbert,Ghadge Shubhangi,Gastineau Thierry,McGoldrick Mic,Nurnaeni Ida,Scheppler Lorenz

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference50 articles.

1. Dellepiane N, Pagliusi S, Regulatory Experts Working Group. Challenges for the registration of vaccines in emerging countries: Differences in dossier requirements, application and evaluation processes. N. Dellepiane, S. Pagliusi and Registration Experts Working Group. Vaccine 2018; 36(24): 3389-3396. Cf. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278877/.

2. Dellepiane N, Pagliusi S, Regulatory Experts Working Group. Opportunities for improving access to vaccines in emerging countries through efficient and aligned registration procedures: An industry perspective. Vaccine 2019; 37: 2982-2989. Cf. https://pubmed.ncbi.nlm.nih.gov/31027928/.

3. Speeding access to vaccines and medicines in low- and middle-income countries: a case for change and a framework for optimized product market authorization;Ahonkhai;PLoS ONE,2016

4. John F. Enders, Ph.D.†,Samuel L. Katz, M.D. et al. Studies on an Attenuated Measles-Virus Vaccine— Development and Preparation of the Vaccine: Technics for Assay of Effects of Vaccination. N Engl J Med 1960; 263:153-159. Cf. https://pubmed.ncbi.nlm.nih.gov/14404830/.

5. Theiler M, Smith HH. The use of yellow fever virus modified by in vitro cultivation for human immunization. J. Exp. Med 1937; 65:787-800. Cf. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2133527/.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling Supply and Demand Dynamics of Vaccines against Epidemic-Prone Pathogens: Case Study of Ebola Virus Disease;Vaccines;2023-12-25

2. How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation;Vaccine;2022-02

3. Addressing vaccine supply challenges in Europe: Expert industry perspective and recommendations;Health Policy;2022-01

4. A Proposal of a Combined Convergence Regulatory Strategy Applied to Post-approval Changes by Latin American Countries, Reducing Workload and Allowing Continuous Improvement to Guarantee the Quality, Safety, and Efficacy of Medicines;Frontiers in Medicine;2021-11-23

5. COVID-19 pandemics Stage II – Energy and environmental impacts of vaccination;Renewable and Sustainable Energy Reviews;2021-10